|
Evaluation of the novel Helicobacter pylori ClariRes Real-Time PCR assay for detection and
Clarithromycin susceptibility testing of H. pylori in stool specimens from symptomatic children. Lottspeich C. y cols.
J Clin Microbiol 2007 (Jun); 45: 1718–1722. |
|
Helicobacter pylori detection and antimicrobial susceptibility testing. Megraud F y col.
Clin Microbiol Rev 2007; 20: 280-322. |
|
VacA and HP-NAP, Ying and Yang of Helicobacter pylori-associated gastric inflammation. D'Elios y cols.
Clinica Chimica Acta 2007. |
|
Helicobacter pylori Infection and the Risk of Gastric Malignancy. Hsu P y cols. Am J Gastroenterol 2007; 102: 1–6. |
|
The Detection, Surveillance and Treatment of Premalignant Gastric Lesions Related to Helicobacter pylori Infection.
de Vries y cols. Helicobacter 2007; 12: 1–15. |
|
Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter
pylori. Rajinikanth y cols. Intern J Pharmaceut 2006. |
|
Susceptibility-guided vs empiric retreatment of Helicobacter pylori infection after treatment failure.
Yahav J y cols. Dig Dis Sci 2006; Nov. |
|
Effect of the Folk Remedy, Bainiku-ekisu, a Concentrate of Prunus mume Juice, on Helicobacter pylori Infection in Humans.
Nakajima S y cols. Helicobacter 2006; 11: 589–591. |
|
Acquisition of Helicobacter pylori infection in Rhesus Macaques is most consistent with oral-oral transmision.
Solnick JV y cols. J Clin Microbiol 2006; 44: 3799-3803. |
|
The Translation of Helicobacter pylori Basic Research to Patient Care. Ernst PB y cols.
Gastroenterology 2006; 130: 188–206. |
|
The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain: Evolution during
disease progression. Jung y cols. PNAS 2006; 103: 9999–10004. |
|
Efficacy of Cranberry Juice on Helicobacter pylori Infection: a Double-Blind, Randomized Placebo-Controlled Trial. Zhang y cols.
Helicobacter 2005; 10: 139–145. |
|
Incidence of Helicobacter felis and the effect of coinfection with Helicobacter pylori on the gastric mucosa
in the african population. Fritz y cols. J Clin Microbiol 2006; 44: 1692–1696. |
|
Helicobacter pylori: A possible association with otitis media with effusion. Yilmaz T. Otolaryngol Head Neck Surg 2006;134:772-777. |
|
Helicobacter pylori Treatment: A Practical Approach. Vakil N. Am J Gastroenterol 2006;101:497–499. |
|
Clarithromycin-resistant genotypes and erradication of Helicobacter pylori. De Francesco y cols. Ann Intern Med 2006; 144: 94-100. |
|
Implications for induction of autoimmunity via activation of
B-1 cells by Helicobacter pylori urease. Yamanishi y cols. Infect Immun 2006; 74: 248-256. |
|
Five-year follow-up study of mother-to-child transmission of
Helicobacter pylori infection detected by a random amplified polymorphic DNA
fingerprinting method. Konno y cols. J Clin Microbiol 2005; 43: 2246-2250. |
|
In vitro antimicrobial susceptibility testing of Helicobacter
felis, H. bizzozeronii and H. salomonis. Van den Bulck y cols. Antimicrob
Agents Chemother 2005 (Jul): 49: 2997-3000. |
|
Pathogen evolution in vivo: genome dynamics of two isolates obtained 9
years apart from a duodenal ulcer patient infected with a single Helicobacter pylori
strain. Prouzet-Mauleon V y cols. J Clin Microbiol 2005 (Ago): 43: 4237-4241. |
|
Real-time PCR detection and frequency of 16S rDNA mutations associated
with resistance and reduced susceptibility to tetracycline in Helicobacter pylori
from England and Wales. Lawson AJ et al. J Antimicrob Chemother 2005; 56: 282-286. |
|
Significance of transiently positive Enzyme-Linked Immunosorbent Assay
results in detection of Helicobacter pylori in stool samples from children.
Haggerty TD, Perry S, Sanchez L, Perez-Perez G, Parsonnet J. J Clin Microbiol 2005
(May); 43: 2220-2223. |
|
The relationship between plasma and gastric ghrelin levels and strain
diversity in Helicobacter pylori virulence. Isomoto y cols. Am J
Gastroenterol 2005 (jun): 100: 1425-1427. |
|
Antimicrobial peptides are among the antagonistic metabolites produced
by Bifidobacterium against Helicobacter pylori. Collado MC y cols. Intern J Antimicrob Agents
2005; 25: 385-391. |
|
Impact of clarithromycin resistance on eradication of Helicobacter
pylori in infected adults. Lee JH y cols. Antimicrob Agents Chemother
2005 (Abr); 49: 1600-1603. |
|
Construction of a recombinant attenuated Salmonella typhimurium
DNA vaccine carrying Helicobacter pylori hpaA. Xu C y cols. World J
Gastroenterol 2005; 11: 114-117. |
|
Helicobacter pylori infection in hemodialysis patients:
Susceptibility to amoxicillin and clarithromycin.
Aydemir S y cols. World J Gastroenterol 2005; 11: 842-845. |
|
Age-dependant accuracy of Helicobacter pylori antibody assays
for adults, with special emphasis on atrophic gastritis.
Salomaa-Rasanen A y cols. Clin Diag Lab Immunol 2004 (Nov); 11: 1185-1188. |
|
Distribution of antibiotic MICs for Helicobacter pylori strains over
a 16-year period in patients from Seoul, South Korea.
Kim JM y cols. Antimicrob Agents Chemother 2004 (Dic); 48: 4843-4847. |
|
Chronic Helicobacter pylori infection with Sydney strain 1 and
a newly identified mouse-adapted strain (Sydney strain 2000) in C57BL/6 and BALB/c mice.
Thompson LJ y cols. Infect Immun 2004 (Ago); 72: 4668-4679. |
|
Implications of molecular genotyping of Helicobacter pylori isolates
from different human populations by genomic fingerprinting of Enterobacterial repetitive
intergenic consensus regions for strains identification and geographic evolution. Hussain MA
y cols. J Clin Microbiol 2004 (Jun); 42: 2372-2378. |
|
Challenge model for Helicobacter pylori infection in human
volunteers. Graham DY y cols. Gut 2004; 53: 1235-1243. |
|
T2182C mutation in 23S rRNA is associated with clarithromycin resistance
in Helicobacter pylori isolates obtained in Bangladesh. Khan R y cols. Antimicrob Agents Chemother 2004 (Sept); 48: 3567-3569. |
|
Functional adaptation of BabA, the H. pylori ABO blood
group antigen binding adhesin. Aspholm-Hurtig M y cols. Science 2004 (Jul); 305: 519-522. |
|
Evaluation of "Helicobacter heilmannii" subtypes in the gastric mucosas
of cats and dogs. Priestnall SL y cols. J Clin Microbiol 2004 (May); 42: 2144-2151. |
|
Characterization of monospecies biofilm formation by Helicobacter
pylori. Cole y cols. J Bacteriol 2004 (May); 186: 3124-3132. |
|
Nutrient shock and incubation atmosphere influence recovery of culturable
Helicobacter pylori from water. Azevedo y cols. Appl Environ Microbiol 2004 (Ene); 70: 490-493. |
|
Concordance of Helicobacter pylori strains within families.
Kivi M y cols. J Clin Microbiol 2003 (Dic); 41: 5604-5608. |
|
Gastric histopathology, iron status and iron deficiency anemia in children with Helicobacter infection.
Baysoy y cols. J Ped Gastroent Nut 2004 (Feb); 38: 146-151. |
|
Helicobacter species in the intestinal mucosa of patients with ulcerative colitis.
Oliveira AG y cols. J Clin Microbiol 2004 (Ene); 42: 284-286. |
|
Helicobacter pylori virulence factors - one part of a big picture. Hocker M, Hohenberger P.
Lancet 2003; 362: 1231-1233. |
|
Metronidazole-resistant Helicobacter pylori is more prevalent in patients
with nonulcer dyspepsia than in peptic ulcer patients in a multiethnic asian population. Lui S-Y y cols.
J Clin Microbiol (Nov) 2003; 41: 5011-5014. |
|
Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents.
Gut 2003; 52: 490-495. |
|
Detection of clarithromycin-resistant Helicobacter
pylori in stool samples. Fontana y cols. J Clin Microbiol 2003
(Agost); 41: 3636-3640. |
|
Helicobacter pylori and pancreatic disease.
Manes G y cols. J Páncreas (online) 2003; 4: 111-116. |
|
Density of Helicobacter pylori may affect
the efficacy of eradication therapy and ulcer healing in patients
with active duodenal ulcers. Lai Y-C y cols. World J Gastroenterol
2003; 9: 1537-1540. |
|
Transient and Persistent Helicobacter pylori Colonization in Native American Children. Pérez-Pérez GI y cols.
J Clin Microbiol 2003 (Jun); 41: 2401-2407.
|
|
Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. Raghunath A y cols.
British Medical Journal 2003; 326: 737-743.
|
|
Association of Helicobacter pylori antioxidant activities with host colonization proficiency. Olczak AA y cols.
Infect Immun 2003; 71: 580-583.
|
|
Effect of different probiotic preparations on Anti-Helicobacter pylori therapy-related side effects: A parallel group, triple blind placebo-controlled study. Cremonini F y cols.
Am J Gastroenterol 2002; 97: 2744-49.
|
|
Clarithromycin resistance among Helicobacter pylori strains isolated from children: Prevalence and study of mechanism of resistance by PCR-Restriction Fragment Length Polymorphism analysis. Alarcón T, Vega AE, Domingo D, Martínez MJ, López-Brea M.
J. Clin. Microbiol. 2003 (Ene); 41: 486-488.
|
|
Helicobacter cetorum sp. nov., a urease-positive Helicobacter species isolated from dolphins and whales. Harper C. G. y cols.
J. Clin. Microbiol. 2002 (Dic); 40: 4536-4543.
|
|
Factores microbiológicos que afectan a la erradicación de
Helicobacter pylori en población adulta y pediátrica. Domingo D. y cols.
Enferm. Infecc. Microbiol. Clin. 2002 (Nov); 20: 431-1.
|
|
New site of modification of 23S rRNA associated with clarithromycin resistance of
Helicobacter pylori clinical isolates. Fontana C y cols.
Antimicrob. Agents Chemother. 2002 (Dic); 46: 3765-3769.
|
|
Helicobacter pylori infection. Suerbaum S & Michetti P.
N. Engl. J. Med. 2002 (Oct 10); 347: 1175-1186.
|
|
Real-Time quantitative PCR for detection of Helicobacter pylori. He y cols.
J Clin Microbiol 2002 (Oct); 40: 3720-3728.
|
|
Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for
Helicobacter pylori infection. Boixeda y cols.
Aliment Pharmacol Ther 2002 (Ago); 16: 1457-1460.
|